GOVX GeoVax Corp: Market Valuation
This daily price chart for GeoVax Labs, Inc. (GOVX) reflects the dynamics of a company with liquidity totaling 0.00 amid cash shortages and research expenditures. The business develops universal treatments for mutating viruses and oncology via T-cell response. The model is scalable: once patents are secured, drug production becomes global with low unit economics.
Comprehensive metric breakdowns and analytics for GeoVax Labs, Inc. (GOVX)
- market price and analyst price targets:
- company stock capitalization data:
- business book valuation details:
- business debt structure and liquidity details:
Total Debt to Capital GeoVax Labs, Inc.|GOVX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital geovax.com|GOVX - Company Aggregate Debts|Debt to Book Capitalization Ratio GeoVax Labs, Inc.|GOVX - Company Long-Term Loans and Borrowings|Company Short-Term Debt GeoVax|Quick Ratio geovax.com
- net income and valuation multiples indicators:
GOVX - Net Profit|Future Profit GeoVax Labs, Inc.|GOVX - Company Value to Net Income|Forward P/E Multiple geovax.com|GOVX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GeoVax Labs, Inc.|GOVX - Operating profit before deduction of amortization|Earnings per share for the last twelve months GeoVax|GOVX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months geovax.com|GOVX - Earnings growth in current year|Net earnings per share growth forecast for next year GeoVax Labs, Inc.
- sales and revenue indicators:
Fundamental company analysis:GOVX (GeoVax Labs Inc)
Market expectations for GeoVax Labs, Inc. (GOVX) are driven by the balance between innovation potential and the current scale of the business. The company's market capitalization is calculated as the product of the current share price and the total number of outstanding securities. This indicator reflects the aggregate value of equity in real-time. For a biotechnology company that outsources the production of DNA vaccines, this metric demonstrates investor confidence in its intellectual property. A stable trend confirms the fundamental resilience of the development strategy.
Key competitors
Market Value Argenx ARGX|BNTX: Market Capitalization|ABVX: Market Valuation|ADMA Biologics (ADMA) - Market Valuation|PTGX (Protagonist Therapeutics Inc) - Market Valuation|IMVT: Market Value|Market Value Kiniksa|Grifols Group - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Therapeutics) - Market Value|Market Capitalization AUPH (auriniapharma.com)|Market Capitalization BioCryst Pharmaceuticals, Inc. BCRX|VERA - Market Value|Market Value DNTH (Dianthus Corp)|pharvaris.com (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc|TRML (tourmalinebio.com) - Market Capitalization|Market Capitalization Intrexon|Market Valuation PHAR (Pharming)|NKTR (Nektar) - Market Value|Market Value upstreambio.com UPB|Market Capitalization zenasbio.com (ZBIO)|IMNM - Market Value|Gossamer Bio Inc (GOSS) - Market Valuation|KalVista Corp (KALV) - Market Value|Market Valuation Septerna Inc|Market Valuation PVLA|Market Capitalization savarapharma.com|Market Value Rigel Pharmaceuticals Inc (RIGL)|AnaptysBio - Market Capitalization|Market Capitalization ATXS (astriatx.com)|enGene Bio (ENGN) - Market Value|RAPT - Market Value|JBIO - Market Capitalization|ACRS: Market Capitalization|Market Value Kyverna (KYTX)|Market Valuation TLSA|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|THTX (Theratechnologies Inc.) - Market Value|Market Value Avalo Therapeutics Inc AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Market Value|AGEN - Market Value|Market Value CLYM (Climb Bio, Inc.)|ZURA: Market Capitalization|aTyr Pharma, Inc. - Market Value|ADAG (Adagene Corp) - Market Capitalization|ikenaoncology.com (IMA) - Market Capitalization|Market Valuation STTK (Shattuck Labs Inc)|Market Capitalization Equillium Inc|Market Capitalization CNTB (connectbiopharm.com)|IMUX: Market Capitalization|Atara Bio - Market Capitalization|IFRX: Market Value|XFOR: Market Capitalization|Market Valuation Adicet Bio Inc.|Market Value Celularity|Market Capitalization INMB (INmune Bio, Inc.)|Market Valuation BRNS (Barinthus Biotherapeutics)|KZR - Market Value|SAB Biotherapeutics Inc. - Market Valuation|Market Value AKTX (Akari Therapeutics plc)|ENLV: Market Valuation|Market Valuation QTTB|EDSA: Market Capitalization|iBio Inc - Market Value|CARM (Carisma Therapeutics Inc.) - Market Capitalization|XTL Biopharmaceuticals, Ltd. (XTLB) - Market Capitalization|Market Capitalization BOLT|HCWB (HCW Biologics) - Market Value|Market Capitalization APVO (Aptevo Therapeutics, Inc.)|Market Value AIM|ADTX: Market Valuation|Market Value GRI (GRI Bio Corp)|XRTX: Market Capitalization|Market Capitalization HIND|Market Value Revelation Biosciences, Inc.|Market Capitalization INDP (Indaptus Therapeutics, Inc.)|Market Capitalization SCNI|CALI (CalciMedica Inc) - Market Value|Market Capitalization AFMD (Affimed NV)|ALLK - Market Valuation|HOOKIPA Pharma Inc. - Market Capitalization|Market Value IGMS (igmbio.com)|iTeos Pharma (ITOS) - Market Value|Ocean Bio - Market Value|TCBP (TC BioPharm (Holdings) Plc) - Market Capitalization|Market Capitalization Third Harmonic Bio, Inc.
